Month: September 2016
-
Trial Testing Diabetes Drug as Parkinson’s Treatment
A clinical trial has started to test a current drug for type 2 diabetes as a treatment for Parkinson’s disease.
-
Nanoparticle Therapy Start-Up Gains $4M in Early Funds
A start-up enterprise developing treatments for autoimmune disorders using protein-laden nanoparticles is raising $4 million in its first venture funding round.
-
Ordinary Smartphones Able to Hack 3-D Printers
A hacker with an everyday smartphone can steal design data from three-dimensional printers, according to a new paper from a university computer science group.
-
$1.2M Challenge Seeking More Accurate Mammograms
A new challenge is seeking better computer models that interpret mammograms with fewer erroneous results, resulting in fewer unneeded medical tests.
-
Small Business Grant Funds Flu Therapy R&D
A biotechnology company in South Dakota is developing an influenza therapy, with backing from a National Institutes of Health program supporting research by small enterprises.
-
Orphan Status Granted for Hemophilia Genome Editing
Treatments using genome-editing techniques for hemophilia B, a rare blood clotting disease, received orphan therapy status from the U.S. Food and Drug Administration.
-
Chip Device Speeds Single Cell Analysis
A microfluidic, or lab-on-a-chip, device speeds the analysis of individual cells, which its developers show can be applied immediately to testing antibiotics.
-
Labor Day, 2016
It’s Labor Day in the U.S., and Science & Enterprise is taking the day off.
-
Nanotech Plastic Textile Dissipates Body Heat
A new plastic textile material developed at Stanford University is shown to reflect sunlight while allowing more heat from the body to escape, keeping people cooler.
-
Takeda Awarded $19.8 Million for Zika Vaccine
Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections.